Madrid, Spain

Juan Carlos Cuevas

This inventor holds 4 USPTO granted patents. Top assignees: Paratek Pharmaceuticals, Inc., Glaxo Wellcome Inc.. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Carlos Cuevas. Retrieved from https://idiyas.com/inventor/juan-carlos-cuevas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Juan Carlos Cuevas: Innovator in Pharmaceutical Compounds

Introduction

Juan Carlos Cuevas is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tetracycline compounds. With a total of 4 patents to his name, Cuevas has established himself as a key figure in innovation within the industry.

Latest Patents

Among his latest patents is the invention of 9-aminoacyl tetracycline compounds and methods of use thereof. This compound, represented by a specific formula, showcases his expertise in creating novel pharmaceutical solutions that can potentially improve treatment options.

Career Highlights

Throughout his career, Juan Carlos Cuevas has worked with prominent companies such as Paratek Pharmaceuticals, Inc. and Glaxo Wellcome Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Jose Maria Fiandor and Araceli Mallo. Their collaborative efforts have likely played a role in advancing the projects they have worked on together.

Conclusion

Juan Carlos Cuevas is a distinguished inventor whose work in pharmaceutical compounds has made a lasting impact. His innovative spirit and dedication to research continue to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…